MSFT vs ZYME · P/E 39, rev $331.84B vs rev $76.3M
Microsoft Corporation (MSFT) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Microsoft Corporation (MSFT) is a software - infrastructure company listed on US. It is led by Satya Nadella.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported MSFT revenue for 2026-06-30 was $331.84B. Net income was $133.75B. Revenue was up 17.8% from 2025-06-30 to 2026-06-30. MSFT currently screens at market cap $3.71T and trailing P/E 38.6.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
MSFT currently screens at market cap $3.71T and trailing P/E 38.6. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the MSFT and ZYME stock pages for the full models.
Not investment advice.